TY - JOUR AU - Rattan, Ashok AU - Kalia, Awdhesh AU - Ahmad, Nishat T1 - Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives T2 - Emerging Infectious Disease journal PY - 1998 VL - 4 IS - 2 SP - 195 SN - 1080-6059 AB - Multidrug-resistant strains of Mycobacterium tuberculosis seriously threaten tuberculosis (TB) control and prevention efforts. Molecular studies of the mechanism of action of antitubercular drugs have elucidated the genetic basis of drug resistance in M. tuberculosis. Drug resistance in M. tuberculosis is attributed primarily to the accumulation of mutations in the drug target genes; these mutations lead either to an altered target (e.g., RNA polymerase and catalase-peroxidase in rifampicin and isoniazid resistance, respectively) or to a change in titration of the drug (e.g., InhA in isoniazid resistance). Development of specific mechanism–based inhibitors and techniques to rapidly detect multidrug resistance will require further studies addressing the drug and drug-target interaction. KW - India DO - 10.3201/eid0402.980207 UR - https://wwwnc.cdc.gov/eid/article/4/2/98-0207_article ER - End of Reference